After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Earlier, Yahoo Finance discussed this stock as it revealed Halozyme Announces Takeda Receives FDA Approval for HYQVIA® Co-formulated with ENHANZE® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, HALO falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $36.04 and fluctuated between $36.94 as its day high and $33.67 as its day low. The current market capitalization of Halozyme Therapeutics Inc. is $4.76B. A total of 3.2 million shares were traded on the day, compared to an average of 1.15M shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, HALO has seen 3 BUY and 3 SELL insider trades, representing the acquisition of 20,000 and the disposition of 20,000 shares. Over the last 12 months, there were 51 BUYs and 46 SELLs from insiders. Insiders purchased 462,623 shares during that period but sold 379,615.
In the most recent transaction, LaBarre Michael J. sold 10,000 shares of HALO for 40.39 per share on Dec 13. After the transaction, the SVP, CHIEF TECHNICAL OFFICER now owns 151,911 company shares. In a previous transaction on Dec 12, LaBarre Michael J. sold 10,000 shares at 39.63 per share. HALO shares that SVP, CHIEF TECHNICAL OFFICER owns now total 151,911.
Among the insiders who sold shares, LaBarre Michael J. disposed of 10,000 shares on Nov 15 at a per-share price of $39.79. This resulted in the SVP, CHIEF TECHNICAL OFFICER holding 151,911 shares of HALO after the transaction. In another insider transaction, LaBarre Michael J. sold 10,000 shares at $39.08 per share on Nov 14. Company shares held by the SVP, CHIEF TECHNICAL OFFICER now total 151,911.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for HALO in the last 3 months, the mean price target is $49.60 with high estimates of $72.00 and low estimates of $28.00. In terms of 52-week highs and lows, HALO has a high of $53.71 and a low of $29.85.
As of this writing, HALO has an earnings estimate of $Halozyme Therapeutics, Inc. per share for the current quarter. EPS was calculated based on a consensus of Halliburton Company estimates, with a high estimate of $MicroCloud Hologram Inc. per share and a lower estimate of $Talos Energy, Inc..
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. HALO’s latest balance sheet shows that the firm has $740.92M in Cash & Short Term Investments as of fiscal 2021. There were $876.67M in debt and $117.15M in liabilities at the time. Its Book Value Per Share was $1.89, while its Total Shareholder’s Equity was $196.95M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HALO is Buy with a score of 4.36.
